Cochlear Ltd (ASX: COH) is one of the world’s leading medical businesses. Cochlear designs, manufactures and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Graeme Clark invented the first device in 1982, allowing first-user Graham Carrick to hear for the first time for 17 years. Some of the most recent modifications allow users to play sound from their phone directly into their implant.
Are Fortescue (ASX:FMG), Cochlear (ASX:COH), Pushpay (ASX:PPH) and Amcor Ltd (ASX:AMC) your COVID-19 “rebound” ASX shares?
The Cochlear Limited (ASX:COH) share price could bounce today following news of a successful capital raising.
The Cochlear Limited (ASX: COH) share price was trading 19.25% lower today following the release of news it would suspend its profit guidance for FY20.
The S&P/ASX 200 (ASX: XJO) Australian share market index ended Monday’s trading session down a jaw-dropping 9.7%. Of course, this follows falls of 20% already this year.
The S&P/ASX 200 (ASX: XJO) finished the day trading at 5539.3, or 4.42% higher, having fallen more than 6% down this morning. That makes today a 10% snap-back for the ASX 200!
The All Ordinaries (ASX: XAO) was trading 0.09% higher, with shares of Cochlear Limited (ASX:COH), Orica Ltd (ASX:ORI) and Sonic Healthcare Limited (ASX:SHL) moving the Australian share market.
The Cochlear Limited (ASX:COH) share price was trading 10% higher at lunchtime following the relase of its half-year financial report.
Cochlear Limited (ASX:COH) shares were down 4% today following their Annual General Meeting (AGM). Is it time to buy Cochlear shares?
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.28% at lunch.
